NFKB1 and diffuse large B-cell lymphoma: For example, in diffuse large B-cell lymphoma (DLBCL), constitutive activation of the NF-κB signaling pathway occurs through the suppressive effect of TNFAIP3 which normally inhibits the activation of this pathway by miR-125b [173].